Overview and Scope
Enteric disease testing diagnoses enteric diseases such as food and water-borne diseases. Microorganisms such as viruses, bacteria, and parasites, cause enteric diseases that affect intestinal health. These pathogens can be contracted by contaminated food and drink and by coming into contact with the excrement of an infected animal or person. Abdominal cramping, vomiting, nausea, and anorexia are common symptoms of enteric disorders, which can cause the body to lose fluids and nutrients. Enteric disease testing involves tests and technologies such as diagnostic assays and rapid tests, testing of stool specimens, complete blood count (CBC) test, blood culture test, urine test, antibody test, and bone marrow test for the diagnosis of the enteric disease-causing agent.

Sizing and Forecast
The enteric disease testing market size has grown strongly in recent years. It will grow from $4.33 billion in 2023 to $4.59 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to water and food safety concerns, increased outbreaks and epidemics, globalization of food supply, increased travel-related infections, regulatory standards.

The enteric disease testing market size is expected to see strong growth in the next few years. It will grow to $5.81 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to integration of telemedicine and remote monitoring, climate change effects, cross-sector collaboration, antimicrobial resistance, emerging enteric pathogens. Major trends in the forecast period include molecular diagnostics, digital health integration, ai and machine learning, adoption of syndromic testing, point-of-care testing.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

Segmentation & Regional Insights
The enteric disease testing market covered in this report is segmented –

1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types
2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography And Spectrometry, Other Technologies
3) By Application: Hospitals, Research Centers, Clinics, Other Applications

North America was the largest region in the enteric disease testing market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

Major Driver Impacting Market Growth
The increasing cases of diarrhea and hemolytic urea syndrome (HUS) are expected to propel the growth of the enteric disease testing market going forward. The major cause of diarrhea disease cases is the consumption of contaminated food and water. The disorder hemolytic urea syndrome (HUS) affects the blood and blood vessels and is most common in children with diarrhea. Diarrheal disease and HUS are among the leading causes of death in children under five. The increasing cases of diarrhea and hemolytic will need testing solutions, raising the demand for enteric disease testing solutions. For instance, according to the Centers for Disease Control and Prevention, diarrhea is the second greatest cause of mortality among children under the age of 5, 801 thousand worldwide, accounting for one out of every nine child deaths every year. Thus, the increasing incidences of enteric diseases will drive the growth of the enteric disease testing market.

Key Industry Players
Major companies operating in the enteric disease testing market include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Quest Consumer Inc., Trinity Biotech plc., Abbott Laboratories, GlaxoSmithKline Plc., Sanofi India Limited., Bayer HealthCare Pharmaceuticals LLC, Fisher Scientific Inc., Bio Rad Laboratories Pvt Ltd., Alere Inc., 3M Company., ALS Limited, Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, Illumina Inc., BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

The enteric disease testing market report table of contents includes:

1. Executive Summary

2. Enteric Disease Testing Market Characteristics

3. Enteric Disease Testing Market Trends And Strategies

4. Enteric Disease Testing Market - Macro Economic Scenario

5. Global Enteric Disease Testing Market Size and Growth

.
.
.

31. Global Enteric Disease Testing Market Competitive Benchmarking

32. Global Enteric Disease Testing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Enteric Disease Testing Market

34. Enteric Disease Testing Market Future Outlook and Potential Analysis

35. Appendix

Top Major Players:

Becton Dickinson and Company

Biomerica Inc.

bioMérieux SA

Bio-Rad Laboratories Inc

Cepheid Inc

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model